A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.

Inclusion Criteria:• Male and female subjects in the age group of 18-60 years with per-sistent or recurrent nasal congestion and/ or rhinorrhea as defined by the symptoms that last for not less than an hour. * Demonstrating baseline average 24 hour TNSS ≥10. * No clinical evidence of infection indicated by mucopurulent or puru-lent discharge, fever, and tenderness over paranasal sinuses. * Subjects who will be able to read and fill-up subject diary efficiently. * Able and willing to give informed consent. * Able and willing to follow all study related instructions and to make all required visits. Exclusion Criteria:• Subjects who have taken systemic, topical corticosteroids, long acting antihistamines or immunosuppressive medication within last 4 weeks or planning to take them within the course of the study. * Acute febrile illness (such as cold, flu etc.) within one week of enroll-ment. * Subjects with nasal structure deformities, nasal polyps, severe deviat-ed nasal septum and hypertrophic rhinitis will be excluded from the study. * Clinical history of allergy/ hypersensitivity to one or more products of herbal origin. * Pregnant / lactating women and women who are planning to get preg-nant * Recent (within last 3 months) participation in a clinical trial * Recent (within last 15 days) use of any herbal product for the indication under study * Patients with severe conditions of chronic sinusitis deviated nasal sep-tum or nasal polyposis. * Bronchial asthma patients on lo…